Full text is available at the source.
Using enzymes to protect crRNA for better CRISPR/Cas12a detection
Updated
Abstract
RI-CRISPR improves detection sensitivity by nearly twentyfold compared to conventional CRISPR/Cas12a.
- The CRISPR/Cas12a system faces challenges due to crRNA instability, which affects its diagnostic performance.
- RNase inhibitor (RI)-assisted CRISPR (RI-CRISPR) effectively prevents crRNA degradation.
- RI-CRISPR enhances the detection performance and anti-interference capability of the CRISPR system.
- Clinical validation with 40 MTB samples demonstrates 100% specificity and 96% sensitivity compared to the GeneXpert assay.
Simplified